Nanovesicular delivery of repaglinide through skin

Science of Advanced Materials

Volumn 5, Issue 7, 2013, Pages 810-821

  Hussain, Gulam ^a   Kohli, Kanchan ^a   Umar, Ahmad ^b   Amin, Saima ^a  

^a HAMDARD UNIVERSITY   (India)

^b NAJRAN UNIVERSITY   (Saudi Arabia)

Author keywords

Box Behnken design; Repaglinide; Transfersomal gel; Transfersome

Indexed keywords

EID: 84881011881     PISSN: 19472935     EISSN: 19472943     Source Type: Journal    
DOI: 10.1166/sam.2013.1522     Document Type: Article

References (38)

1. S. Jain, P. Jain, R. B. Umamaheshwari, and N.K Jain, Drug. Dev. Ind. Pharm. 29, 1013 (2003).
2. E. Maghraby, G. M. M. Williams, and A, C. Barry, J. Pharm. Pharmacol. 53, 1311 (2001).
3. G. K. Menon, Adv. Drug Deliv. Rev. 54, S3 (2002).
4. M. Mezei and V. Gulasekharam, Life Sci. 26, 1473 (1980).
5. G. Cevc and G. Blume, Biochim. Biophys. Acta 1104, 226 (1992).
6. H. A. E. Benson, Expert Opin. Drug Deliv. 3, 727 (2006).
7. G. Cevc, Transfersomes, Crit. Rev. Ther. Drug Carrier Syst. 13, 257 (1996).
8. S. Pandey, Der. Pharmacia. Letter 1, 143 (2009).
9. The Merck Index, 12th edn., Monograph No. 8304, 1399 (1996).
10. J. E. F. Reynolds, Martindale, 33rd edn., The Complete Drug Reference Pharmaceutical Press, London (2002), p. 334.
11. C. R. Culy and B. Jarvis, Drugs 61, 1625 (2001).
12. ® (repaglinide)Product Monograph, Novo Nordisk Canada Inc. (2010), pp. 1-41.
13. Clark's Analysis of Drugs and Poisons, pharmaceutical Press, Electronic Version, London (2005).
14. P. Karande and S. Mitragotri, Biochim. Biophys. Acta 1788, 2362 (2009).
15. M. Gandhimathi, T. K. Ravi, and S, K. Renu, Anal. Sci. 19, 1675 (2003).
16. M. K. Rawat, A. Jain, and S, Singh, J. Pharm. Sci. 100, 2366 (2011).
17. G. Cevc, G. Blume, and A, Schatzlein, J. Control. Releas. 45, 211 (1997).
18. E. L. Maghraby, G. M. M. Williams, and A, C. Barry, J. Pharm. Pharmacol. 51, 1123 (1999).
19. S. Mura, M. Manconi, C. Sinico, D. Valenti, and A, M. Fadda, Int. J. Pharm. 380, 72 (2009).
20. F. Shakeel, S. Baboota, A. Ahuja, J. Ali, and S, Shafiq, J. Nanobiotech. 6, 1 (2008).
21. S. Sultana, B. Iqbal, Z. Panda, B. P. Talegaonkar, and S, Bhatnagar, J. Microencapsul. 26, 385 (2009).
22. R. Gannu, C. R. Palem, S. K. Yamsani, V. V. Yamsani, and M, R. Yamsani, AAPS Pharm. Sci. Tech. 11, 976 (2010).
23. H. Chaudhary, K. Kohli, S. Amin, P. Rathee, and V. Kumar, J. Pharm. Sci. X, 1 (2010).
24. M. Shumilov and E. Touitou, Int. J. Pharm. 387, 26 (2010).
25. F. Shakeel, W. Ramadan, H. M. Gargum, and R, Singh, Sci. Pharm. 78, 47 (2010).
26. A. Ahad, M. Aqil, K. Kohli, Y. Sultana, M. Mujeeb, and A, Ali, Nanomedicin. 8, 237 (2012).
27. E. Touitou, N. Dayan, L. Bergelson, B. Godin, and M, Eliaz, J. Control. Releas. 65, 403 (2000).
28. A. Kim, M. O. Yun, Y. K. Oh, W. S. Ahn, and C, K Kim, Int. J. Pharm. 180, 75 (1999).
29. Y. Lu, Y. Zhang, Z. Yang, and X, Tang, Int. J. Pharm. 366, 160 (2009).
30. V. Bergh, P. W. Wertz, H. E. Junginger, and J, A. Bouwstra, Int. J. Pharm. 217, 13 (2001).
31. D. Mishra, M. Garg, V. Dubey, S. Jain, and N, K. Jain, J. Pharm. Sci. 96, 145 (2007).
32. J. Lasch, J. Hoffman, W. G. Amelyaneenka, A. A. Klibanov, V. P. Torchilin, and H, Binder, Biochim. Biophys. Act. 1022, 171 (1990).
33. C. Lopez, A. Maza, L. Coderch, I. L. Lpez, E. Wehli, and J, L. Parra, FEBS Lett. 426, 314 (1998).
34. G. Cevc, Adv. Drug. Del. Rev. 56, 675 (2004).
35. S. K. Jain, Y. Gupta, A. Jain, and K, Rai, Drug Deliv. 15, 141 (2008).
36. G. Cevc, D. Gebauer, J. Stieber, S. Andreas, and G, Blume, Biochim. Biophys. Act. 1368, 201 (1998).
37. G. Cevc, G. Blume, A. Schatzlein, D. Gebauer, and A, Paul, Adv. Drug. Deliv. Rev. 18, 349 (1996).
38. R. Cavalli, A. Bargoni, V. Podio, and E, Muntoni, J. Pharm. Sci. 92, 1085 (2003).